In turn, we have expanded previous knowledge on acquired resistance to palbociclib by confirming CCNE1 overexpression/amplification and reduced expression/loss of RB1 as common events that occur at the time of acquired resistance in luminal BC cell lines, independent of HER2 status. This evidence concerns the gene CCNE1 and breast cancer.